Safety outcomes We found numerically higher rates of sICH in the TNK group, although these differences did not reach statistical significance (OR 2.07, 95% CI [0.86–5.00], P =0.1) ( Figure 5A ).
← all excerpts
Tenecteplase Beyond 4.5 Hours in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
2
0.1000
0.1000
The sentences
Our analysis showed a trend towards increased sICH in TNK-treated patients with odds of sICH being 2.07 times higher in the TNK group, with similar trends observed for PH types 1 and 2.